Company: FTII
Filing Date: 2025-04-09
Form Type: 10-K
Source: 0001641172-25-003384
Chunk: 937

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-04-09
Form: 10-K
Item: Item 3
Chunk 937
---
, on April 23, 2024, the Company received a written notice (the “Notice”) from the Staff of Nasdaq Stock
Market LLC (the “Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the Company’s Market
Value of Listed Securities was below the minimum of $50 million required for continued listing on The Nasdaq Global
Market (the “Market Value Standard”) pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “Rule”). The Staff also
noted that the Company did not meet the requirements under Nasdaq Listing Rule 5450(b)(3)(A) (the “Total Assets/Total Revenue Standard”).
An indicator will be displayed with quotation information related to the Company’s securities on NASDAQ.com and NASDAQTrader.com
and may be displayed by other third-party providers of market data information, however, the Notice did not impact the listing of the
Company’s securities on The Nasdaq Global Market at this time.

The
Notice provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company had a period of 180 calendar days from the date
of the Notice, or until October 21, 2024 to regain compliance with the Market Value Standard.

On
October 23, 2024, the Company received a notice from the Staff (the “Staff’s Determination”) stating that the Company
has not regained compliance with the Rule and the Company’s securities would be delisted from the Nasdaq Global Market unless the
Company requested an appeal of Staff’s Determination by October 30, 2024 or applied to list its securities on The Nasdaq Capital
Markets by October 30, 2024.

On
October 29, 2024, the Company timely appealed the Staff’s Determination and requested for a hearing (the “Hearing”)
to the Hearings Panel (the “Panel”). On October 30, 2024, the Company received a letter from Nasdaq stating that the delisting
action has been stayed, pending a final written decision by the Panel, and that the date of the Hearing will be December 17, 2024. The
letter also contained hearing instructions. On November 27, 2024, the Company timely submitted written materials setting forth grounds
for additional time to regain compliance or alternatively grant the Company’s application to transfer its shares to list on the
Nasdaq Capital Market